Research Area: Cardiovascular.

Description

This group comprises physicians and econometrists of the Girona and Barcelona Health Regions with an interest in the study of the measurement of blood pressure, subclinical vascular disease associated with hypertension and the dynamic behaviour of cardiovascular risk factors. They collaborate with other investigators and networks within the IDIAP and other research bodies. The main objective of the group is to contribute information on 3 aspects of the role of blood pressure self-measurement (BPSM) with regard to the diagnosis of hypertension: 1.- Cut-off points of normality for the diagnosis of isolated clinical hypertension in relation to intermediate (evolution of subclinical vascular disease) and final variables (cardiovascular and renal morbidity and mortality ); 2.- Criteria for the diagnosis of isolated clinical hypertension or white coat hypertension; 3.- Optimal protocol for BPSM. The relationship between hypertension and subclinical vascular disease is concomitantly analysed. The research areas of this group are as follows: 1. Description of the normality cut-off points, the optimal protocol for measurement and diagnostic and prognostic value of BPSM; 2. Clinical validation of an automated screening of retinal microvasculature; 3. Assessment of the dynamic behaviour of metabolic syndrome and its components and cardiovascular morbidity and mortality; 4. Validation of specific cardiovascular risk tables for patients with Type 2 Diabetes.

Research Lines

Optimization of subclinical vascular disease in the diagnosis and follow-up of patients with hypertension, Measurement of blood pressure outside the examination room, Metabolic syndrome and cardiovascular risk.

Members

Projects

Group projects

PI: Coll de Tuero, Gabriel. Reproductibilitat de diversos protocols de mesura per determinar la diferència de pressió arterial entre braços en els pacients amb sospita d'Hipertensió Arterial (ARM-DIF Study). Funding: Fundació Catalana Hipertensio. Duration: 2017 - 2019

PI: Rodriguez Poncelas, Antonio. Asociación entre la administración de inhibidores de la bomba de protocones y la incidencia de enfermedad renal crónica y lesión renal aguda en población general. Funding: IDIAP Jordi Gol. Duration: 2017 - 2019

PI: Mata Cases, José Manuel. Caracterización del riesgo cardiovascular antes del primer evento cardiovascular prematuro en Catalunya. Funding: Departament de Salut. Duration: 2017 - 2019

PI: Cerezo Goyeneche, Carlos. Ensayo híbrido de evaluación de una intervención compleja multiriesgo para promover conductas saludables en personas de 45-75 años atendidas en Atención Primaria: estudio EIRA3. Subproyecto Girona. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2018

PI: Coll de Tuero, Gabriel. Comportamiento dinámico del síndrome metabólico y elaboración de una ecuación para predecir el riesgo cardiovascular en los pacientes con Diabetes tipo 2 de una cohorte retrospectiva obtenida a partir de una base de datos clínico administrativa. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2018

PI: Llauger Rosselló, Maria Antònia. Proyecto PASHOS: Plataforma Avanzada para el estudio del Síndrome de Apnea Hipopnea Obstructiva del Sueño (SAHS). Estudio multicéntrico de validación de un modelo de criba del SAHS en Atención Primaria. Funding: ICS - Institut Català de la Salut. Duration: 2017

Publications

The group participates in the following publications:

Barceló MA, Rodríguez-Poncelas A, Saez M, Coll-de-Tuero G. The dynamic behaviour of metabolic syndrome and its components in an eight-year population-based cohort from the Mediterranean. PloS one. 2017; 12(5):e0176665. doi:10.1371/journal.pone.0176665. Epub 2017 May 18. pmc:PMC5436648. PMID:28545089. IF: 2,806.

Coll de Tuero, Gabriel, Vargas-Vila S, Torguet P. Is Persistent Office Hypertension in Treated Hypertensive Patients a Benign Condition? Journal of clinical hypertension (Greenwich, Conn.). 2017 Jan; 19(1):11-12. doi:10.1111/jch.12919. Epub 2016 Sep 28. PMID:27677716. IF: 3,242.

Sicras-Mainar A, Navarro-Artieda R, Ruiz-Torrejón A, Saez M, Coll-de Tuero G, Sánchez L. A retrospective, observational and multicentre study on patients with hyperactive bladder on treatment with mirabegron and oxybutinine under usual clinical practice conditions. Semergen. 2017 May; 43(4):277-288. doi:10.1016/j.semerg.2016.05.006. Epub 2016 Jun 28. Spanish. PMID:27371430.

Sicras-Mainar A, Navarro-Artieda R, Sáez-Zafra M. Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in Spain. Gastroenterologia y hepatologia. 2018 Apr; 41(4):234-244. doi:10.1016/j.gastrohep.2017.11.008. Epub 2017 Dec 26. PMID:29287992. IF: 0,917.

Indicators